Amgen Inc. (AMGN): Price and Financial Metrics

AMGN POWR Grades

• Quality is the dimension where AMGN ranks best; there it ranks ahead of 98.82% of US stocks.
• AMGN's strongest trending metric is Growth; it's been moving up over the last 163 days.
• AMGN's current lowest rank is in the Momentum metric (where it is better than 12.47% of US stocks).

AMGN Stock Summary

• AMGN has a higher market value than 98.15% of US stocks; more precisely, its current market capitalization is $128,931,564,968.
• The capital turnover (annual revenue relative to shareholder's equity) for AMGN is 3.14 -- better than 85.12% of US stocks.
• AMGN's went public 36.08 years ago, making it older than 92.74% of listed US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to Amgen Inc are SNY, IBM, MDT, BMY, and DE.
• Visit AMGN's SEC page to see the company's official filings. To visit the company's web site, go to www.amgen.com.

AMGN Valuation Summary

• In comparison to the median Healthcare stock, AMGN's price/sales ratio is 55.95% lower, now standing at 5.
• Over the past 243 months, AMGN's price/earnings ratio has gone down 35.2.
• Over the past 243 months, AMGN's price/sales ratio has gone down 13.1.

Below are key valuation metrics over time for AMGN.

AMGN Growth Metrics

The 5 year cash and equivalents growth rate now stands at 165.44%.
• Its 5 year net cashflow from operations growth rate is now at -2.32%.
• Its 5 year net income to common stockholders growth rate is now at 6.36%.

Over the past 15 months, AMGN's revenue has gone up $1,466,000,000.

The table below shows AMGN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	25,767	8,606	5,609
2021-06-30	25,484	9,556	5,746
2021-03-31	25,164	10,467	7,085
2020-12-31	25,424	10,497	7,264
2020-09-30	24,987	10,858	7,352
2020-06-30	24,301	10,867	7,299

AMGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AMGN has a Quality Grade of A, ranking ahead of 98.04% of graded US stocks.
• AMGN's asset turnover comes in at 0.412 -- ranking 113th of 682 Pharmaceutical Products stocks.
• UTHR, NBY, and AERI are the stocks whose asset turnover ratios are most correlated with AMGN.

The table below shows AMGN's key quality metrics over time.